Blockade of this compound's second receptor is the most likely cause of neuroleptic-malignant syndrome.
This neurotransmitter is secreted by neurons in cell groups A8 through A14. Agonists of its receptors are used to treat restless legs syndrome. Blockade of this compound's second receptor is the most likely cause of neuroleptic-malignant syndrome. It is used extensively by a pathway that stretches to the nucleus accumbens from the ventral (*) tegmental area called the mesolimbic pathway. Both typical and atypical antipsychotics block this compound's receptors. It is preferentially secreted by a group of cells in the basal ganglia called the substantia nigra, whose degeneration results in a neurodegenerative disease with tremors and a shuffling gait. For 10 points, name this neurotransmitter involved in pleasure and reward, which is underproduced in Parkinson's disease.
This neurotransmitter is secreted by neurons in cell groups A8 through A14.
dopamine [or 3,4-dihydroxyphenethylamine]